...
机译:MYH9基因的非洲血统等位基因变异导致西班牙裔美国人对非糖尿病终末期肾脏疾病的易感性增加
Molecular Medicine Laboratory, Rambam Health Care Campus, Haifa 31096, Israel,;
Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv 69978, Israel,;
Ruth and Bruce Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 31096, Israel,;
Molecular Medicine Laboratory, Rambam Health Care Campus, Haifa 31096, Israel,|Ruth and Bruce Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 31096, Israel,;
Ruth and Bruce Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 31096, Israel,;
Computer Science Department, Technion - Israel Institute of Technology, Haifa 32000, Israel,;
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA,;
Labor;
机译:MYH9基因的非洲血统等位基因变异导致西班牙裔美国人对非糖尿病终末期肾脏疾病的易感性增加。
机译:APOL1等位基因变异与较低的透析起始年龄相关,从而在患有非糖尿病终末期肾脏疾病的非洲裔和西班牙裔美国人中增加了透析年龄
机译:APOL1等位基因变体与较低的透析开始年龄相关,从而在患有非糖尿病终末期肾脏疾病的非洲人和西班牙裔美国人中增加了透析时间
机译:采用基于研究中心的指导计划,增加非洲裔美国人,西班牙裔和美洲原住民在工程中的参与
机译:评估非洲人和欧洲人对2型糖尿病相关的终末期肾脏疾病和相关表型易感性的遗传变异。
机译:MYH9基因的非洲血统等位基因变异导致西班牙裔美国人对非糖尿病终末期肾脏疾病的易感性增加
机译:MYH9基因的非洲血统等位基因变异导致西班牙裔美国人对非糖尿病终末期肾脏疾病的易感性增加